Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	411.29	351.19	551.8	640.19	565.78
Short-Term Investments	4.85	4.35	6.51	61.04	311.87
Cash & Short-Term Investments	416.14	355.54	558.31	701.23	877.65
Cash Growth	17.04%	-36.32%	-20.38%	-20.10%	149.34%
Accounts Receivable	271.72	224.5	29.17	80.1	25
Other Receivables	-	-	8.71	-	-
Receivables	271.72	224.5	37.88	80.1	25
Inventory	82.48	162.66	99.7	24	-
Prepaid Expenses	9.51	8.59	7.18	5.17	3.4
Restricted Cash	1.32	1.11	1.27	1.56	1.27
Other Current Assets	7.78	13.93	15.18	11.98	9.88
Total Current Assets	788.95	766.33	719.52	824.05	917.19
Property, Plant & Equipment	19.04	21.09	24.9	26.08	24.52
Long-Term Accounts Receivable	-	-	15	30	18
Other Long-Term Assets	77.06	1.31	0.8	1.64	0.86
Total Assets	885.05	788.73	760.22	881.77	960.57
Accounts Payable	38.57	37.52	37.34	16.91	8.48
Accrued Expenses	140.18	127.81	95.14	103.24	111.94
Current Portion of Leases	6.75	6.44	5.63	4.12	3.69
Other Current Liabilities	-	75.83	29.5	7.58	4.23
Total Current Liabilities	185.51	247.59	167.61	131.85	128.33
Long-Term Debt	452.83	93.03	92.74	189.02	358.83
Long-Term Leases	10.2	11.45	14.35	17.08	15.22
Other Long-Term Liabilities	7.97	242.13	315.65	345.15	253.64
Total Liabilities	656.51	594.21	590.35	683.1	756.01
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,267	3,036	2,480	1,857	1,131
Retained Earnings	-3,035	-2,837	-2,309	-1,657	-926.35
Comprehensive Income & Other	-3.31	-3.54	-0.88	-2.09	-0.12
Total Common Equity	228.54	194.52	169.87	198.66	204.56
Shareholders' Equity	228.54	194.52	169.87	198.66	204.56
Total Liabilities & Equity	885.05	788.73	760.22	881.77	960.57
Total Debt	469.78	110.93	112.71	210.22	377.73
Net Cash (Debt)	-53.65	244.61	445.59	491.01	499.92
Net Cash Growth	-	-45.10%	-9.25%	-1.78%	156.43%
Net Cash Per Share	-0.43	2.06	4.20	5.82	6.65
Filing Date Shares Outstanding	125.52	120.58	111.29	97.73	80.38
Total Common Shares Outstanding	124.5	119.56	110.77	97.52	76.13
Working Capital	603.45	518.74	551.91	692.2	788.87
Book Value Per Share	1.84	1.63	1.53	2.04	2.69
Tangible Book Value	228.54	194.52	169.87	198.66	204.56
Tangible Book Value Per Share	1.84	1.63	1.53	2.04	2.69

Source: S&P Capital IQ. Standard template. Financial Sources.